Khalilull Khatri, MD
Dermatology · Chelmsford, MANPI 1033169610
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 376 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 32.1% of the total.
Across 376 payments — averaging $25.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Lilly USA, LLC$1K
- Amgen$650
- Sanofi$597
- Galderma Laboratories, L.p.$597
- Sun Pharmaceutical Industries Inc.$590
- plus $3K from 19 others
Across 8 payments — averaging $15,220 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$122K
What the payments were for
- Food & beverage$9,36198%
- Education$1562%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 123 | $3,054 |
| Lilly USA, LLC | 53 | $1,258 |
| Amgen | 16 | $650 |
| Sanofi | 35 | $597 |
| Galderma Laboratories, L.p. | 10 | $597 |
| Sun Pharmaceutical Industries Inc. | 22 | $590 |
| Johnson & Johnson | 20 | $550 |
| Pfizer | 28 | $467 |
| Novartis | 14 | $389 |
| UCB, Inc. | 16 | $331 |
| E.r. Squibb & Sons, L.L.C. | 8 | $183 |
| Regeneron Healthcare Solutions, Inc. | 7 | $179 |
| Merz North America, Inc. | 4 | $177 |
| Incyte Corporation | 5 | $115 |
| Bristol Myers Squibb | 3 | $76 |
| Sanofi-aventis U.S. LLC | 1 | $72 |
| LEO Pharma Inc. | 2 | $44 |
| Strata Skin Sciences, Inc. | 2 | $42 |
| Mayne Pharma Commercial LLC | 1 | $27 |
| Tempus AI, Inc | 1 | $27 |
| Boehringer Ingelheim | 1 | $24 |
| Sientra, Inc. | 1 | $22 |
| Sandoz | 1 | $17 |
| Organon | 1 | $16 |
| Botanix SB Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,517 in reported general payments places this provider in the 80th percentile of 552 dermatology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 35 | $1,731 |
| Doxycycline Hyclate | 26 | $723 |
| Triamcinolone Acetonide | 43 | $541 |
| Doxycycline Monohydrate | 39 | $388 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Chelmsford
- John HarrisWorcester$15M
- Ethan LernerCharlestown$1.7M
- Michael KaminerChestnut Hill$1.1M
- Jeffrey SobellChestnut Hill$986K
- Erik DominguesFall River$736K
- Alexandra KimballBoston$680K
- Arash MostaghimiBoston$591K
- David GreensteinBeverly$540K
- Brian HiblerBoston$498K
- Maryanne SennaBoston$430K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.